Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapyMarco Cerrano, Raphaël Itzykson, Étienne Lengliné et al.|Leukemia|2020Cited by 20
A multiparametric niche-like drug screening platform in acute myeloid leukemiaReinaldo Dal Bello, Raphaël Itzykson, Hervé Dombret et al.|Blood Cancer Journal|2022Cited by 13